{"id":"medication-optimization","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2108889","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is not a discrete pharmaceutical agent but rather a healthcare delivery intervention developed by the VA Office of Research and Development. It involves evidence-based assessment of medication appropriateness, dosing, drug-drug interactions, and deprescribing to enhance efficacy and safety. The approach is typically applied across multiple therapeutic areas and patient populations.","oneSentence":"Medication optimization is a clinical practice framework aimed at improving therapeutic outcomes by systematically reviewing, adjusting, and personalizing drug regimens for individual patients.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:54:08.817Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07030166","phase":"","title":"A Machine Learning Prediction Model for Postoperative Acute Kidney Injury in Non-Cardiac Surgery Patients","status":"RECRUITING","sponsor":"Lanyue Zhu","startDate":"2025-07-01","conditions":"Kidney Injury, Acute","enrollment":10000},{"nctId":"NCT06112418","phase":"NA","title":"A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events","status":"RECRUITING","sponsor":"Cleerly, Inc.","startDate":"2024-03-06","conditions":"Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome","enrollment":7500},{"nctId":"NCT07498725","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors","status":"NOT_YET_RECRUITING","sponsor":"LARKSPUR BIOSCIENCES, INC.","startDate":"2026-05","conditions":"Neoplasms","enrollment":120},{"nctId":"NCT06630806","phase":"PHASE1","title":"A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-10-30","conditions":"Plasma Cell Myeloma Refractory","enrollment":87},{"nctId":"NCT07283783","phase":"NA","title":"INCLUDE Program: A Perioperative Wellness Program Tailored for Black Surgical Patients","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-01-05","conditions":"Surgery","enrollment":50},{"nctId":"NCT06561711","phase":"PHASE4","title":"Optimization of Minocycline for Helicobacter Pylori Rescue Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2024-08-21","conditions":"Helicobacter Pylori Infection","enrollment":480},{"nctId":"NCT01036581","phase":"NA","title":"Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging","status":"RECRUITING","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2003-10-24","conditions":"Drug Abuse, Nicotine Dependence","enrollment":1000},{"nctId":"NCT06465069","phase":"PHASE1","title":"A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2024-07-01","conditions":"Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor","enrollment":420},{"nctId":"NCT04008797","phase":"PHASE1, PHASE2","title":"A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eisai Inc.","startDate":"2019-07-11","conditions":"Endometrial Neoplasms, Neoplasms, Carcinoma, Hepatocellular","enrollment":301},{"nctId":"NCT07462663","phase":"","title":"SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer","status":"NOT_YET_RECRUITING","sponsor":"Hospital Universitari de Bellvitge","startDate":"2026-05","conditions":"Endometrial Cancer, Endometrial Cancer Stage I, Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I","enrollment":82},{"nctId":"NCT06580938","phase":"PHASE1","title":"A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer","status":"TERMINATED","sponsor":"Pfizer","startDate":"2024-11-11","conditions":"Non Small Cell Lung Cancer, Bladder Cancer, Renal Cell Carcinoma","enrollment":4},{"nctId":"NCT06188559","phase":"PHASE2","title":"A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eisai Inc.","startDate":"2024-04-10","conditions":"Breast Cancer","enrollment":135},{"nctId":"NCT06842498","phase":"PHASE2","title":"A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)","status":"RECRUITING","sponsor":"Kyntra Bio","startDate":"2026-02-22","conditions":"Metastatic Castration-Resistant Prostate Cancer","enrollment":75},{"nctId":"NCT03635073","phase":"PHASE2","title":"A Study of Soticlestat in Adults and Children With Rare Epilepsies","status":"TERMINATED","sponsor":"Takeda","startDate":"2018-07-19","conditions":"Epilepsy, Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS)","enrollment":156},{"nctId":"NCT07482917","phase":"NA","title":"Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial","status":"RECRUITING","sponsor":"Hospital de Granollers","startDate":"2026-03-09","conditions":"Interstitial Lung Disease (ILD), Suspected Interstitial Lung Disease, Fibrotic Interstitial Lung Disease","enrollment":92},{"nctId":"NCT06596473","phase":"PHASE1","title":"A Study of BG-C477 in Participants With Advanced Solid Tumors","status":"RECRUITING","sponsor":"BeOne Medicines","startDate":"2024-10-03","conditions":"Advanced Solid Tumors","enrollment":310},{"nctId":"NCT07090499","phase":"PHASE1","title":"A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-08-20","conditions":"Advanced/Metastatic Solid Tumors, Bladder Cancer, Urothelial Carcinoma","enrollment":310},{"nctId":"NCT07222267","phase":"PHASE1","title":"An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors","status":"RECRUITING","sponsor":"BeOne Medicines","startDate":"2025-12-11","conditions":"Breast Cancer, Advanced Solid Tumor","enrollment":86},{"nctId":"NCT00571389","phase":"","title":"A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.","status":"RECRUITING","sponsor":"BioCytics, Inc.","startDate":"2007-11","conditions":"Solid Tumor, Adult, Healthy Donors, COVID-19 Donors","enrollment":1500},{"nctId":"NCT07220616","phase":"PHASE1, PHASE2","title":"A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies","status":"RECRUITING","sponsor":"Daiichi Sankyo","startDate":"2026-01-16","conditions":"Hematological Malignancies","enrollment":420},{"nctId":"NCT07478887","phase":"NA","title":"Impact of the Corrie Lipids Digital Health Program on Lipid Optimization","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-06-20","conditions":"Cardiovascular Risk, LDL-C, Lipids","enrollment":1000},{"nctId":"NCT05464030","phase":"PHASE1","title":"Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)","status":"RECRUITING","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2022-08-04","conditions":"Colorectal Cancer","enrollment":200},{"nctId":"NCT06157892","phase":"PHASE2","title":"A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors","status":"RECRUITING","sponsor":"Seagen, a wholly owned subsidiary of Pfizer","startDate":"2024-05-20","conditions":"Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms","enrollment":172},{"nctId":"NCT04419480","phase":"NA","title":"Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial","status":"RECRUITING","sponsor":"Inova Health Care Services","startDate":"2020-12-31","conditions":"Cardiogenic Shock, Heart Failure, Ambulatory Hemodynamic Monitoring","enrollment":40},{"nctId":"NCT06871488","phase":"PHASE4","title":"Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants","status":"RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2026-03-05","conditions":"ADHD - Attention Deficit Disorder With Hyperactivity, Irritability, Aggression Childhood","enrollment":136},{"nctId":"NCT04300556","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types","status":"RECRUITING","sponsor":"Eisai Inc.","startDate":"2020-08-06","conditions":"Solid Tumor","enrollment":182},{"nctId":"NCT07470853","phase":"PHASE1","title":"A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.","status":"RECRUITING","sponsor":"Whitehawk Therapeutics, Inc.","startDate":"2026-03-15","conditions":"PROC, Platinum Resistant Ovarian Cancer, Endometrial Cancer","enrollment":265},{"nctId":"NCT07070232","phase":"PHASE1, PHASE2","title":"A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors","status":"RECRUITING","sponsor":"BioNTech SE","startDate":"2025-08-12","conditions":"Advanced Solid Tumor","enrollment":980},{"nctId":"NCT07206225","phase":"PHASE1","title":"A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-11-06","conditions":"Non-muscle Invasive Bladder Cancer","enrollment":294},{"nctId":"NCT07465159","phase":"NA","title":"Multimodal Prehabilitation of Frail Patients Undergoing Elective Knee or Hip Replacement","status":"NOT_YET_RECRUITING","sponsor":"University of Iceland","startDate":"2026-04-01","conditions":"Frailty Syndrome, Prehabilitation, Arthroplasties, Knee Replacement","enrollment":50},{"nctId":"NCT07460219","phase":"NA","title":"Veterans Affairs Pharmacist Heart Failure Medication Titration Project 2","status":"ENROLLING_BY_INVITATION","sponsor":"Stanford University","startDate":"2025-07-16","conditions":"Quality Improvement, Pharmacotherapy, Heart Failure","enrollment":400},{"nctId":"NCT06013007","phase":"NA","title":"Joint Inflation With Nominal-pressure and Stability Approach in DES Optimization","status":"COMPLETED","sponsor":"Zunyi Medical College","startDate":"2023-08-22","conditions":"Acute Coronary Syndrome, De Novo Stenosis","enrollment":161},{"nctId":"NCT04040023","phase":"NA","title":"Patient Blood Management in Cardiac Surgery","status":"COMPLETED","sponsor":"Clinique Pasteur","startDate":"2019-09-10","conditions":"Surgical Blood Loss","enrollment":900},{"nctId":"NCT07454577","phase":"NA","title":"Nurse Led Interventions on Functional Trajectories, Sleep Quality, and Psychological Distress in Hemodialysis Patients","status":"COMPLETED","sponsor":"Norther Private Collage of Nursing","startDate":"2025-08-05","conditions":"Nursing Interventions","enrollment":220},{"nctId":"NCT07453719","phase":"NA","title":"Feasibility Pilot Trial of Med Management in COPD","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-04-01","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":92},{"nctId":"NCT07451496","phase":"NA","title":"PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS)","status":"RECRUITING","sponsor":"National University of Singapore","startDate":"2025-09-29","conditions":"Ageing","enrollment":20},{"nctId":"NCT07109219","phase":"PHASE1, PHASE2","title":"Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-11-12","conditions":"B-cell Acute Lymphoblastic Leukemia (B-ALL)","enrollment":83},{"nctId":"NCT06657222","phase":"PHASE1, PHASE2","title":"First in Human Study of TUB-030 in Patients With Advanced Solid Tumors","status":"RECRUITING","sponsor":"Tubulis GmbH","startDate":"2024-12-13","conditions":"Advanced Solid Tumors, HNSCC, SCLC","enrollment":250},{"nctId":"NCT07435558","phase":"NA","title":"Homogeneous vs. Heterogeneous Learning Style Grouping in Problem-Based Learning Among Nurses","status":"NOT_YET_RECRUITING","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2026-03-07","conditions":"Problem-based Learning in Nursing Education, Nurses, Randomized Clinical Trial","enrollment":78},{"nctId":"NCT07225660","phase":"NA","title":"Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)","status":"RECRUITING","sponsor":"Shady Grove Fertility Reproductive Science Center","startDate":"2026-02-25","conditions":"Fertility Preservation","enrollment":394},{"nctId":"NCT07046923","phase":"PHASE1","title":"A Study of LY4175408 in Participants With Advanced Cancer","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-07-28","conditions":"Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Endometrial Neoplasms","enrollment":240},{"nctId":"NCT07439536","phase":"PHASE4","title":"Dose Optimization of Sitagliptin and Duloxetine in Diabetic Cirrhosis","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2024-07-01","conditions":"Liver Cirrhosis With Diabetes","enrollment":64},{"nctId":"NCT07361562","phase":"PHASE1","title":"A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors","status":"RECRUITING","sponsor":"Cogent Biosciences, Inc.","startDate":"2025-12-30","conditions":"Advanced Solid Tumor, Adult, ERBB2 Altered Breast Cancer, ERBB2 Gene Amplification","enrollment":100},{"nctId":"NCT06346067","phase":"PHASE3","title":"A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Erasca, Inc.","startDate":"2024-04-29","conditions":"Advanced or Metastatic NRAS-mutant Melanoma","enrollment":78},{"nctId":"NCT07422012","phase":"","title":"Tacrolimus in Pregnancy","status":"NOT_YET_RECRUITING","sponsor":"Baylor Research Institute","startDate":"2026-03","conditions":"Unbound Tacrolimus in Pregnant Uterus Transplant Recipients, Whole Blood Tacrolimus in Pregnant Uterus Transplant Recipients","enrollment":55},{"nctId":"NCT05912647","phase":"NA","title":"Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2024-02-03","conditions":"Diabetes, Diabetes Type 2","enrollment":376},{"nctId":"NCT05081609","phase":"PHASE1, PHASE2","title":"A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ascendis Pharma Oncology Division A/S","startDate":"2022-01-11","conditions":"Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor","enrollment":320},{"nctId":"NCT07190469","phase":"PHASE1","title":"PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer","status":"RECRUITING","sponsor":"ProteinQure Inc.","startDate":"2025-09-16","conditions":"Triple Negative Breast Cancer (TNBC), Advanced Solid Tumors Cancer","enrollment":80},{"nctId":"NCT07288359","phase":"PHASE1, PHASE2","title":"Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-12-29","conditions":"Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer","enrollment":205},{"nctId":"NCT07419464","phase":"PHASE2","title":"5-Fluorouracil Response and Optimization STudy (The FROST Trial)","status":"NOT_YET_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-05-31","conditions":"Squamous Cell Carcinoma of Head and Neck, Metastatic Squamous Cell Carcinoma, Recurrent Squamous Cell Carcinoma of the Head and Neck","enrollment":46},{"nctId":"NCT06919822","phase":"NA","title":"SCAN Targeted Epidural Modulation for Parkinson's Disease","status":"RECRUITING","sponsor":"Changping Laboratory","startDate":"2025-12-08","conditions":"Parkinson Disease","enrollment":3},{"nctId":"NCT06886789","phase":"NA","title":"SMART to Optimize an Intervention to Maintain Health Improvements After Cardiac Rehabilitation","status":"RECRUITING","sponsor":"The Miriam Hospital","startDate":"2026-03-02","conditions":"Cardiovascular Diseases, Cardiac Rehabilitation","enrollment":400},{"nctId":"NCT06750549","phase":"NA","title":"Mobile Application for Patient Engagement and Physician-Directed Remote Management of Heart Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Michigan","startDate":"2025-02-18","conditions":"Heart Failure","enrollment":130},{"nctId":"NCT05967195","phase":"EARLY_PHASE1","title":"Trial to Increase FEP Attendance","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2025-02-01","conditions":"First-Episode Psychosis","enrollment":145},{"nctId":"NCT07413419","phase":"NA","title":"Evaluation of Remote Motivational Interviewing for Disease Management in Heart Failure Patients and Their Carers","status":"NOT_YET_RECRUITING","sponsor":"Wroclaw Medical University","startDate":"2026-02-28","conditions":"Heart Failure (HF), Self Care, Caregiver","enrollment":600},{"nctId":"NCT07396051","phase":"NA","title":"Rehabilitation Exercise Against Complications in High-risk Elderly After Lumbar Fusion(REACH)","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-01-25","conditions":"Adjacent Segment Degeneration, Multimodal Rehabilitation, Lumber Fusion","enrollment":212},{"nctId":"NCT07238075","phase":"PHASE1","title":"ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers","status":"RECRUITING","sponsor":"Adcytherix SAS","startDate":"2026-02-14","conditions":"Advanced Malignancy, Advanced Solid Cancers, Metastatic Solid Tumors","enrollment":290},{"nctId":"NCT07414836","phase":"PHASE1","title":"A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors","status":"NOT_YET_RECRUITING","sponsor":"BeOne Medicines","startDate":"2026-04-30","conditions":"Advanced Solid Tumor","enrollment":84},{"nctId":"NCT07412626","phase":"NA","title":"Evaluation of the HeartLogic Diagnostic in Optimizing Guideline-directed Medical Therapy in Patients With Congestive Heart Failure and Chronically Low Ejection Fractions (EFs)","status":"NOT_YET_RECRUITING","sponsor":"Robert Pickett","startDate":"2026-04-01","conditions":"Congestive Heart Failure Chronic, Low Ejection Fraction","enrollment":135},{"nctId":"NCT05470439","phase":"NA","title":"My Interprofessional Care Team for Adherence and Research Engagement Disparities","status":"RECRUITING","sponsor":"University of Arizona","startDate":"2023-08-30","conditions":"Medication Adherence, Hypertension","enrollment":217},{"nctId":"NCT06094920","phase":"PHASE4","title":"Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2024-07-29","conditions":"Diabetes Mellitus Type 2 With Proteinuria, Diabetes Mellitus, Type 2, Diabetes Mellitus","enrollment":12},{"nctId":"NCT05197270","phase":"PHASE1, PHASE2","title":"4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration","status":"RECRUITING","sponsor":"4D Molecular Therapeutics","startDate":"2021-12-09","conditions":"Neovascular (Wet) Age-Related Macular Degeneration","enrollment":215},{"nctId":"NCT06845774","phase":"NA","title":"The PROTECT (PrEP Optimization Through Telehealth Care and Treatment) Trial","status":"ENROLLING_BY_INVITATION","sponsor":"Hilary L Surratt, PhD","startDate":"2025-09-25","conditions":"HIV Prevention","enrollment":80},{"nctId":"NCT07407920","phase":"PHASE2","title":"Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-10-09","conditions":"Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Early Stage HER2-Positive Breast Carcinoma","enrollment":120},{"nctId":"NCT07394582","phase":"NA","title":"Preoperative Optimization Before Total Hip or Knee Replacement Surgery","status":"RECRUITING","sponsor":"Medical University Innsbruck","startDate":"2026-02-05","conditions":"Prehabilitation, Preoperative Care","enrollment":180},{"nctId":"NCT06238479","phase":"PHASE1","title":"A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2024-03-05","conditions":"Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor","enrollment":490},{"nctId":"NCT05432765","phase":"NA","title":"AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function","status":"NOT_YET_RECRUITING","sponsor":"University of Florida","startDate":"2026-12","conditions":"Kidney Transplant Rejection","enrollment":34},{"nctId":"NCT06960655","phase":"NA","title":"Improving Lipid Optimization Quality and Treatment Options in ASCVD","status":"ENROLLING_BY_INVITATION","sponsor":"Brigham and Women's Hospital","startDate":"2025-10-14","conditions":"Hypercholesterolemia, ASCVD","enrollment":300},{"nctId":"NCT06299514","phase":"NA","title":"RAFT - Pace &Ablate","status":"RECRUITING","sponsor":"Habib Khan","startDate":"2024-04-25","conditions":"Atrial Fibrillation, Heart Failure, Pacemaker","enrollment":600},{"nctId":"NCT07136779","phase":"PHASE1, PHASE2","title":"First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies","status":"RECRUITING","sponsor":"VelaVigo Bio Inc","startDate":"2025-09-23","conditions":"Participants With Advanced Solid Tumor Malignancies","enrollment":310},{"nctId":"NCT06792552","phase":"PHASE1","title":"A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors","status":"RECRUITING","sponsor":"NextCure, Inc.","startDate":"2025-02-26","conditions":"Advanced Solid Tumors","enrollment":414},{"nctId":"NCT07374718","phase":"NA","title":"Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk","status":"NOT_YET_RECRUITING","sponsor":"Shenyang Northern Hospital","startDate":"2026-03-01","conditions":"Acute Coronary Syndrome (ACS), High Bleeding Risk(HBR), Coronary Artery Disease (CAD)","enrollment":468},{"nctId":"NCT06599099","phase":"NA","title":"Deep Brain Stimulation of Treatment-Resistant Bipolar Depression","status":"RECRUITING","sponsor":"Wayne Goodman MD","startDate":"2025-01-01","conditions":"Bipolar Depression","enrollment":10},{"nctId":"NCT07259148","phase":"NA","title":"Behavioral Interventions Versus Pelvic Floor Muscle Therapy as Adjuncts to Anticholinergic Pharmacotherapy for Urgency Urinary Incontinence: A Non-Inferiority Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emilio José Dávila Álvarez","startDate":"2025-11-22","conditions":"Urgency Urinary Incontinence","enrollment":80},{"nctId":"NCT07349979","phase":"NA","title":"PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-01-30","conditions":"Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease","enrollment":654},{"nctId":"NCT07354828","phase":"","title":"Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy","status":"NOT_YET_RECRUITING","sponsor":"Shenyang Northern Hospital","startDate":"2025-12-30","conditions":"Acute Coronary Syndrome (ACS), High Bleeding Risk (HBR), Coronary Artery Disease (CAD)","enrollment":3500},{"nctId":"NCT07347834","phase":"","title":"TRIOCOL - The Study of Continued Advanced Medical Therapy or Colectomy in Patients With Ulcerative Colitis","status":"RECRUITING","sponsor":"Region Stockholm","startDate":"2024-10-22","conditions":"Ulcerative Colitis (UC)","enrollment":500},{"nctId":"NCT07354217","phase":"PHASE4","title":"Workflow Optimization During Pulse Field Ablation for Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2026-01-01","conditions":"Pulsed Field Ablation, Lidocaine","enrollment":60},{"nctId":"NCT06915428","phase":"NA","title":"Personalized Care for Prenatal Stress Reduction & Prevention of Preterm Birth (PTB) Disparities","status":"NOT_YET_RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2026-02-01","conditions":"Preterm Birth Complication, Preterm Birth, Preterm Birth Recurrence","enrollment":1228},{"nctId":"NCT07353385","phase":"NA","title":"Enhanced Efficacy Through Optimization of Hemoporfin-Photodynamic Therapy Parameters in Port-Wine Stains","status":"COMPLETED","sponsor":"Second Affiliated Hospital of Xi'an Jiaotong University","startDate":"2024-07-01","conditions":"Port Wine Stains","enrollment":33},{"nctId":"NCT06228014","phase":"","title":"Pilot Study: AI Algorithm for Dermatology Referral Optimization","status":"COMPLETED","sponsor":"AI Labs Group S.L","startDate":"2022-11-23","conditions":"Skin Diseases, Skin Condition","enrollment":200},{"nctId":"NCT05858320","phase":"PHASE3","title":"The Impact of an Adaptive Patient-centered Web Application on Medication Optimization in HFrEF Patients","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2023-07-21","conditions":"Heart Failure","enrollment":225},{"nctId":"NCT06400472","phase":"PHASE1","title":"A Study of LY4170156 in Participants With Selected Advanced Solid Tumors","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2024-05-20","conditions":"Ovarian Neoplasms, Endometrial Neoplasms, Uterine Cervical Neoplasms","enrollment":495},{"nctId":"NCT07336446","phase":"PHASE1, PHASE2","title":"A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs","status":"NOT_YET_RECRUITING","sponsor":"AstraZeneca","startDate":"2026-01-05","conditions":"Prostate Cancer","enrollment":300},{"nctId":"NCT07216365","phase":"PHASE2","title":"Caffeine Optimization for Oxygen Saturation Index in ELBW Infants","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-03-01","conditions":"Neonatal Apnea, Infants","enrollment":40},{"nctId":"NCT07332468","phase":"NA","title":"Digital Remote Management for Care and Continuous Optimization Versus Usual Care to Reduce Risk of Atherosclerotic Cardiovascular Diseases (DigiCare-ASCVD)","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2026-01","conditions":"Atherosclerotic Cardiovascular Diseases","enrollment":790},{"nctId":"NCT07332494","phase":"NA","title":"Digital Remote Management for Care and Continuous Optimization Versus Usual Care in Patients With Coronary Heart Disease (DigiCare-CHD)","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2026-01","conditions":"Coronary Heart Disease, Percutaneous Coronary Intervention","enrollment":792},{"nctId":"NCT07216846","phase":"NA","title":"The Geriatric Emergency Department Pharmacologic Harm Prevention Project","status":"RECRUITING","sponsor":"Florida Atlantic University","startDate":"2026-01-01","conditions":"Fall, Fall Accident, Poly Pharmacy","enrollment":1000},{"nctId":"NCT07312019","phase":"NA","title":"Optimization of Medical Time in the Emergency Department: Impact of an AI-Based System on Prescription Entry","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2026-01","conditions":"Drug-related Iatrogenesis, Emergency Department, Artificial Intelligence","enrollment":770},{"nctId":"NCT06265727","phase":"PHASE1, PHASE2","title":"A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors","status":"RECRUITING","sponsor":"Corbus Pharmaceuticals Inc.","startDate":"2024-04-01","conditions":"Solid Tumor, Adult","enrollment":348},{"nctId":"NCT06781983","phase":"PHASE1","title":"Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors","status":"RECRUITING","sponsor":"Innate Pharma","startDate":"2025-01-24","conditions":"Advanced or Metastatic Solid Tumors","enrollment":145},{"nctId":"NCT05405595","phase":"PHASE1, PHASE2","title":"ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors","status":"RECRUITING","sponsor":"Adagene Inc","startDate":"2022-06-15","conditions":"Advanced/Metastatic Solid Tumors","enrollment":186},{"nctId":"NCT05623306","phase":"NA","title":"SEEG-Guided DBS for OCD","status":"RECRUITING","sponsor":"Casey H. Halpern, M.D.","startDate":"2023-04-13","conditions":"Obsessive-Compulsive Disorder","enrollment":10},{"nctId":"NCT06399757","phase":"PHASE1, PHASE2","title":"A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors","status":"RECRUITING","sponsor":"Apollo Therapeutics Ltd","startDate":"2024-06-18","conditions":"Colorectal Cancer, Cholangiocarcinoma, Appendiceal Adenocarcinoma","enrollment":100},{"nctId":"NCT03754114","phase":"NA","title":"Brain Oxygen Optimization in Severe TBI, Phase 3","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2019-08-28","conditions":"Brain Injuries, Traumatic","enrollment":1094},{"nctId":"NCT07124117","phase":"PHASE1, PHASE2","title":"A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors","status":"RECRUITING","sponsor":"OBI Pharma, Inc","startDate":"2025-08-04","conditions":"Advanced Solid Tumor","enrollment":147},{"nctId":"NCT07311824","phase":"NA","title":"Pain Management for In-Office Gynecologic Procedures Using a Risk-Stratification Pain Calculator","status":"NOT_YET_RECRUITING","sponsor":"Carle Foundation Hospital","startDate":"2025-12-29","conditions":"Pain Management, Patient Satisfaction, Gynecologic Procedures","enrollment":200},{"nctId":"NCT07312331","phase":"NA","title":"SOC-based Behavioral Intervention to Promote Walking","status":"COMPLETED","sponsor":"Ling Yang","startDate":"2025-02-01","conditions":"Older Adults, Older Adults (65 Years and Older)","enrollment":350},{"nctId":"NCT07299747","phase":"PHASE1, PHASE2","title":"Clinical Trial of VBC103 in Patients With Advanced Malignant Solid Tumors","status":"RECRUITING","sponsor":"VelaVigo Bio Inc","startDate":"2025-12-04","conditions":"Participants With Advanced Solid Tumor Malignancies","enrollment":255},{"nctId":"NCT06381115","phase":"NA","title":"App-Based Optimization of Long-Term CPAP Adherence and Quality of Life","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-06-01","conditions":"Obstructive Sleep Apnea","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":340,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Medication optimization","genericName":"Medication optimization","companyName":"VA Office of Research and Development","companyId":"va-office-of-research-and-development","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}